<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H86EAE24B21964CB196B925B9E52021B9" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 5741 IH: Options Over Terminations Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2021-10-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5741</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20211026">October 26, 2021</action-date><action-desc><sponsor name-id="N000189">Mr. Newhouse</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HGO00">Committee on Oversight and Reform</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To provide an exemption to any Federal COVID–19 vaccine mandate for any Federal employee or contractor who provides proof of COVID–19 antibodies, and for other purposes.</official-title></form><legis-body id="H9F38095AFA7B4B828166C6B793615CEE" style="OLC"><section id="H2C49A82A6FEB4CE482FFB5F37A41234B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Options Over Terminations Act</short-title></quote>.</text></section><section id="HB38831CCAD5E423D949C1BD3C6516B0C"><enum>2.</enum><header>Exemption to COVID–19 vaccine mandates for Federal employees or contractors with COVID–19 antibodies</header><subsection id="HE54B5925CDE646A9928EC608E2B5F2EF"><enum>(a)</enum><header>Federal employees</header><paragraph id="HF8CA832970D94BF1BFBA00BBF32D58F8"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Notwithstanding any other law, rule, or regulation, including Executive Order 14043 (86 Fed. Reg. 50989; relating to requiring coronavirus disease 2019 vaccination for Federal employees), any Federal employee who provides proof of COVID–19 antibodies to their employing agency, in such form and manner as the employing agency may require, shall be exempt from any Federal mandate requiring a vaccine for COVID–19.</text></paragraph><paragraph id="HC3D1526CCAD542E6A8D551C68C2BB38A"><enum>(2)</enum><header>Reimbursement</header><text>Subject to the availability of appropriations, the employing agency shall reimburse any Federal employee at that agency for the costs of any COVID–19 antibody test for the purposes of carrying out paragraph (1).</text></paragraph><paragraph id="H0CCAFEDAEA324355A6E1E92C304E15D4"><enum>(3)</enum><header>Prohibition on adverse action</header><text>No adverse action (including a suspension, furlough, removal, or reduction in pay or grade) may be taken against any Federal employee who elects to meet the requirements of the exemption described in paragraph (1). </text></paragraph><paragraph id="H99EDB4780D3D41AD901A08A0064A3F0D"><enum>(4)</enum><header>Employee defined</header><text>In this subsection, the term <term>Federal employee</term> has the meaning given the term <term>employee</term> in section 2105 of title 5, United States Code, and includes—</text><subparagraph id="HFF784503196443A0A96B21EE460DA6F2"><enum>(A)</enum><text>an officer or employee of the United States Postal Service or of the Postal Regulatory Commission; and</text></subparagraph><subparagraph id="H75C5032B3417478BA707CFA15EE25061"><enum>(B)</enum><text>an employee appointed under chapter 73 or 74 of title 38, United States Code, notwithstanding section 7425(b) of such title.</text></subparagraph></paragraph></subsection><subsection id="H2AB3E88DA7174DB4AECC150DBFA28718"><enum>(b)</enum><header>Federal contractors</header><text>Any contract entered into by the Federal Government that requires any employee or individual described under that contract, or any subcontract (at any tier), to receive a COVID–19 vaccination shall include—</text><paragraph id="H1A3D7F5DDC1D41BE9CD4A8B0E46765CD"><enum>(1)</enum><text display-inline="yes-display-inline">an exemption from such requirement for any such employee or individual who provides proof of the presence of COVID–19 antibodies;</text></paragraph><paragraph id="H31987CD0EACF491FA9F302A5C9B906E6"><enum>(2)</enum><text display-inline="yes-display-inline">a requirement that any such employee or individual who so provides proof shall be reimbursed, at the expense of the Federal Government, for the cost of any applicable COVID–19 antibody test; and</text></paragraph><paragraph id="HE5E0C12C8E554E77BFACBB3AEF1D4901"><enum>(3)</enum><text display-inline="yes-display-inline">a requirement that the contractor may not retaliate against any employee who elects to meet the requirements of the exemption described in paragraph (1).</text></paragraph></subsection></section></legis-body></bill> 

